Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CING
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Cingulate Inc. stock price down 0.338% on Thursday
(Updated on May 09, 2024)

Sell candidate since May 03, 2024 Loss -8.25% PDF

The Cingulate Inc. stock price fell by -0.338% on the last day (Thursday, 9th May 2024) from $0.89 to $0.89. During the last trading day the stock fluctuated 4.65% from a day low at $0.86 to a day high of $0.90. The price has risen in 6 of the last 10 days and is up by 5.36% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -29 thousand shares and in total, 24 thousand shares were bought and sold for approximately $20.87 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -24.31% during the next 3 months and, with a 90% probability hold a price between $0.512 and $0.83 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CING Signals & Forecast

There are mixed signals in the stock today. The Cingulate Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.95 and $0.97. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Monday, May 06, 2024, and so far it has risen 1.64%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Cingulate Inc. stock

Cingulate Inc. finds support from accumulated volume at $0.88 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0400 between high and low, or 4.65%. For the last week the stock has had daily average volatility of 14.19%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CING) For The Upcoming Trading Day Of Friday 10th

For the upcoming trading day on Friday, 10th we expect Cingulate Inc. to open at $0.88, and during the day (based on 14 day Average True Range), to move between $0.785 and $0.98, which gives a possible trading interval of +/-$0.0996 (+/-11.25%) up or down from last closing price. If Cingulate Inc. takes out the full calculated possible swing range there will be an estimated 22.51% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.88 (0.67%) than the resistance at $1.07 (20.90%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Cingulate Inc. stock A Buy?

Cingulate Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -3.128 Sell Candidate Unchanged

Predicted Opening Price for Cingulate Inc. of Friday, May 10, 2024

Fair opening price May 10, 2024 Current price
$0.88 ( 0.377%) $0.89

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CING

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.92 4.14 %
R2 0.91 2.42 %
R1 0.90 1.35 %
Current price: 0.89
Support S1 0.87 -2.10 %
S2 0.86 -3.17 %
S3 0.84 -4.90 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.09 23.16 %
R2 1.08 22.03 %
R1 1.07 20.90 %
Current price 0.89
Support S1 0.88 -0.667%
S2 0.85 -3.75%
S3 0.780 -11.86%

FAQ

What is the symbol for Cingulate Inc. Stock and on which exchange is it traded?
The symbol for Cingulate Inc. is CING and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Cingulate Inc. Stock?
Cingulate Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Cingulate Inc. Stock?
Cingulate Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cingulate Inc. Stock.

What's the current price of Cingulate Inc. Stock?
As of the end of day on the May 09, 2024, the price of an Cingulate Inc. (CING) share was $0.89.

What is the 52-week high and low for Cingulate Inc. Stock?
The 52-week high for Cingulate Inc. Stock is $12.70 and the 52-week low is $0.275.

What is the market capitalization of Cingulate Inc. Stock?
As of the May 09, 2024, the market capitalization of Cingulate Inc. is 3.52M.
Click to get the best stock tips daily for free!

About Cingulate Inc.

Cingulate. Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficit/hyperactivity disorder. The company's lead product candidates are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, and CTx-1302 (dextroamphetamine) for the treatment of attention-deficit/hyperactivity disorders. It also focuses on developing CTx-2103 for the treatment of anxiety diso... CING Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT